Clinical Trial Update: A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) [Phase 1]

View source ↗

Summary

A Phase I dose-escalation combination study in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Myelogenous Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Phase 1 | Status: TERMINATED